Kymera Therapeutics, Inc. (KYMR)
108.09
+3.31
(+3.16%)
USD |
NASDAQ |
Oct 19, 12:33
Kymera Therapeutics Gross Profit Margin (Quarterly) : 96.88% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 96.88% |
| March 31, 2026 | 94.12% |
| December 31, 2025 | 29.20% |
| September 30, 2025 | 22.25% |
| June 30, 2025 | 81.84% |
| March 31, 2025 | 90.73% |
| December 31, 2024 | 73.32% |
| September 30, 2024 | 46.54% |
| June 30, 2024 | 92.59% |
| March 31, 2024 | 85.42% |
| December 31, 2023 | 98.19% |
| September 30, 2023 | 80.96% |
| June 30, 2023 | 94.55% |
| March 31, 2023 | 90.49% |
| Date | Value |
|---|---|
| December 31, 2022 | 94.93% |
| September 30, 2022 | 91.62% |
| June 30, 2022 | 93.92% |
| March 31, 2022 | 92.72% |
| December 31, 2021 | 95.49% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 80.31% |
| September 30, 2019 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 72.58% |
| Twist Bioscience Corp. | 52.76% |
| Beam Therapeutics, Inc. | -1.00K% |
| Arrowhead Pharmaceuticals, Inc. | 91.15% |
| Oncolytics Biotech, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -22.88% |
| Return on Assets | -20.55% |
| Return on Invested Capital | -21.53% |
| Profit Margin (Quarterly) | -94.17% |
| Operating Margin (Quarterly) | -116.3% |
| Return on Net Operating Assets | -304.1% |